{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:43Z","timestamp":1793121523730,"version":"4.5.0"},"reference-count":148,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>As lifestyle patterns change, the rates of type 2 diabetes and obesity are increasing together, leading to an increase in metabolic-associated fatty liver disease (MAFLD), now recognized as the most frequently occurring liver disease globally. MAFLD presents a significant threat to public health and imposes a substantial socioeconomic burden. This condition encompasses a spectrum of hepatic manifestations, beginning with excessive fat accumulation and hepatic steatosis, and possibly progressing to non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis, and liver cancer. The pathogenesis of MAFLD is intricately linked to lipid accumulation, oxidative stress, and lipotoxicity. Notably, the interleukin-6 (IL-6) cytokine family plays a complex role in the onset and development of MAFLD, primarily through the modulation of lipid metabolism, insulin resistance, inflammatory responses, and liver fibrosis. This review examines the impact of the IL-6 family on the progression of MAFLD. It explores targeting the IL-6 family as a potential future therapy for MAFLD.<\/jats:p>","DOI":"10.3389\/fendo.2025.1642436","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:12:28Z","timestamp":1756872748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiale","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciren","family":"Pubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease-A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41467-017-00102-9","article-title":"Negri bodies are viral factories with properties of liquid organelles","volume":"8","author":"Nikolic","year":"2017","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD)-pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530120303","article-title":"Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily","volume":"12","author":"Hirano","year":"1994","journal-title":"Stem Cells"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190347","article-title":"Historical overview of the interleukin-6 family cytokine","volume":"217","author":"Kang","year":"2020","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.04.007","article-title":"Inborn errors of IL-6 family cytokine responses","volume":"72","author":"Chen","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7512","article-title":"Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine","volume":"87","author":"Paul","year":"1990","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1191228","article-title":"Editorial: IL-27 in health and disease","volume":"14","author":"Imamichi","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395921","article-title":"IL-27 expression regulation and its effects on adaptive immunity against viruses","volume":"15","author":"Andres-Martin","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170704122559","article-title":"Oncostatin M: potential implications for Malignancy and metabolism","volume":"23","author":"Stephens","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.4960","article-title":"Endothelin\u22121 induces oncostatin M expression in osteoarthritis osteoblasts by trans\u2212activating the oncostatin M gene promoter via Ets\u22121","volume":"13","author":"Wu","year":"2016","journal-title":"Mol Med Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609655200","article-title":"Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells","volume":"282","author":"Chattopadhyay","year":"2007","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structures and biological functions of IL-31 and IL-31 receptors","volume":"19","author":"Zhang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6887","article-title":"IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis","volume":"8","author":"Fassett","year":"2023","journal-title":"Sci Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04127-5","article-title":"IL-27 signalling promotes adipocyte thermogenesis and energy expenditure","volume":"600","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.08.011","article-title":"Structural organization of a full-length gp130\/LIF-R cytokine receptor transmembrane complex","volume":"31","author":"Skiniotis","year":"2008","journal-title":"Mol Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1002\/j.1460-2075.1987.tb02742.x","article-title":"Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF)","volume":"6","author":"Gearing","year":"1987","journal-title":"EMBO J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.12.016","article-title":"Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases","volume":"31","author":"Wang","year":"2023","journal-title":"Mol Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.007","article-title":"Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies","volume":"26","author":"Pasquin","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305717120","article-title":"CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes","volume":"120","author":"Ding","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2019.07.038","article-title":"CNTF and nrf2 are coordinately involved in regulating self-renewal and differentiation of neural stem cell during embryonic development","volume":"19","author":"Si","year":"2019","journal-title":"iScience"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.20.11458","article-title":"Novel neurotrophin-1\/B cell-stimulating factor-3: a cytokine of the IL-6 family","volume":"96","author":"Senaldi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020992","article-title":"CRLF1 and CLCF1 in development, health and disease","volume":"23","author":"Crisponi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32719","article-title":"Intrahepatic paracrine signaling by cardiotrophin-like cytokine factor 1 ameliorates diet-induced NASH in mice","volume":"78","author":"Liu","year":"2023","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-019-0371-7","article-title":"TGF-\u03b21\/IL-11\/MEK\/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency","volume":"52","author":"Chen","year":"2020","journal-title":"Exp Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1290130","article-title":"Roles of IL-11 in the regulation of bone metabolism","volume":"14","author":"Han","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.29421","article-title":"Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice","volume":"67","author":"Matsuda","year":"2018","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1242\/dev.122.2.419","article-title":"Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival","volume":"122","author":"Sheng","year":"1996","journal-title":"Development"},{"key":"B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/1359-6101(96)00007-x","article-title":"Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways","volume":"7","author":"Pennica","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.05.006","article-title":"Crosstalk between endothelial cells and dermal papilla entails hair regeneration and angiogenesis during aging","volume":"70","author":"Zhou","year":"2025","journal-title":"J Adv Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2090693","article-title":"Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis","volume":"19","author":"Akkoc","year":"2023","journal-title":"Autophagy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104806","article-title":"IL11 stimulates ERK\/P90RSK to inhibit LKB1\/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells","volume":"25","author":"Widjaja","year":"2022","journal-title":"iScience"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07701-9","article-title":"Inhibition of IL-11 signalling extends mammalian healthspan and lifespan","volume":"632","author":"Widjaja","year":"2024","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239732","article-title":"The clinical relevance of OSM in inflammatory diseases: a comprehensive review","volume":"14","author":"Wolf","year":"2023","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J Intern Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20023","article-title":"Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver","volume":"39","author":"Bugianesi","year":"2004","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1304-z","article-title":"Hepatic vagus nerve regulates Kupffer cell activation via \u03b17 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis","volume":"52","author":"Nishio","year":"2017","journal-title":"J Gastroenterol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol Aspects Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31889","article-title":"The emerging role of B cells in the pathogenesis of NAFLD","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through rictor\/akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.12.017","article-title":"Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders","volume":"66","author":"Hassan","year":"2014","journal-title":"Cytokine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq1984","article-title":"Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism","volume":"8","author":"Yeudall","year":"2022","journal-title":"Sci Adv"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511x-10-110","article-title":"Inflammatory stress exacerbates ectopic lipid deposition in C57BL\/6J mice","volume":"10","author":"Mei","year":"2011","journal-title":"Lipids Health Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160794","article-title":"A stress signaling pathway in adipose tissue regulates hepatic insulin resistance","volume":"322","author":"Sabio","year":"2008","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121221","article-title":"Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin","volume":"3","author":"Arora","year":"2018","journal-title":"JCI Insight"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101946","article-title":"Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice","volume":"298","author":"Yuan","year":"2022","journal-title":"J Biol Chem"},{"key":"B78","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41467-024-44924-w","article-title":"Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20989","article-title":"IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia","volume":"58","author":"Baker","year":"2010","journal-title":"Glia"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2011.47","article-title":"Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis","volume":"91","author":"Henkel","year":"2011","journal-title":"Lab Invest"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2006.02.003","article-title":"The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes","volume":"1761","author":"P\u00e9rez","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.10.015","article-title":"Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway","volume":"351","author":"Uotani","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s12565-017-0421-y","article-title":"Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target","volume":"93","author":"Komori","year":"2018","journal-title":"Anat Sci Int"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201802095","article-title":"The cell biology of systemic insulin function","volume":"217","author":"Tokarz","year":"2018","journal-title":"J Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","article-title":"A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids Health Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.9.6839","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss","volume":"85","author":"Bastard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2007.01044.x","article-title":"The dual function of hepatic SOCS3 in insulin resistance in vivo","volume":"12","author":"Torisu","year":"2007","journal-title":"Genes Cells"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019712","article-title":"Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus","volume":"27","author":"Rehman","year":"2017","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B95","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus","volume":"26","author":"Danforth","year":"2000","journal-title":"Nat Genet"},{"key":"B96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.461905","article-title":"Lack of oncostatin M receptor \u03b2 leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype","volume":"288","author":"Komori","year":"2013","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol Rev"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200107000-00004","article-title":"Cytokines in the liver","volume":"13","author":"Ramadori","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30774","article-title":"IL-6 trans-signaling controls liver regeneration after partial hepatectomy","volume":"70","author":"Fazel Modares","year":"2019","journal-title":"Hepatology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1154-0","article-title":"Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6\/STAT3 signaling in mice","volume":"51","author":"Cai","year":"2016","journal-title":"J Gastroenterol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122565","article-title":"Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology","volume":"345","author":"Zahra","year":"2024","journal-title":"Life Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1640","article-title":"The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression","volume":"9","author":"Kim","year":"2008","journal-title":"Nat Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121974","article-title":"The effect of hepatic stellate cell derived-IL-11 on hepatocyte injury in hepatic fibrosis","volume":"330","author":"Jiang","year":"2023","journal-title":"Life Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2015.11.009","article-title":"Interleukin-11 protects mouse liver from warm ischemia\/reperfusion (WI\/Rp) injury","volume":"40","author":"Yu","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41598-023-30582-3","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1159\/000374096","article-title":"Pathophysiology of liver fibrosis","volume":"33","author":"Pinzani","year":"2015","journal-title":"Dig Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"Tacke","year":"2015","journal-title":"J Hepatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40779-023-00494-4","article-title":"Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-\u03baB pathways","volume":"10","author":"Zhang","year":"2023","journal-title":"Mil Med Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107376","article-title":"The increase of long noncoding RNA Fendrr in hepatocytes contributes to liver fibrosis by promoting IL-6 production","volume":"300","author":"Kang","year":"2024","journal-title":"J Biol Chem"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PloS One"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu Rev Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/s1359-6101(00)00003-4","article-title":"Role of Oncostatin M in hematopoiesis and liver development","volume":"11","author":"Miyajima","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010028","article-title":"A profibrogenic mediator overexpressed in non-alcoholic fatty liver disease, stimulates migration of hepatic myofibroblasts","volume":"9","author":"Foglia","year":"2019","journal-title":"Cells"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)80066-5","article-title":"Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells","volume":"32","author":"Levy","year":"2000","journal-title":"J Hepatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1145","article-title":"Interleukins-17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation","volume":"2","author":"Guillot","year":"2018","journal-title":"Hepatol Commun"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149671","article-title":"Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis","volume":"703","author":"Cho","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312797","article-title":"Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD","volume":"22","author":"Mavromati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1173826","article-title":"Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease","volume":"14","author":"Wen","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1996.271.3.E521","article-title":"which share the gp130 transduction system, stimulate hepatic lipid metabolism in rats","volume":"271","author":"Nonogaki","year":"1996","journal-title":"Am J Physiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/1440-1681.12709","article-title":"Alleviative effect of ciliary neurotrophic factor analogue on high fat-induced hepatic steatosis is partially independent of the central regulation","volume":"44","author":"Cui","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade4395","article-title":"Structural insights into the assembly of gp130 family cytokine signaling complexes","volume":"9","author":"Zhou","year":"2023","journal-title":"Sci Adv"},{"key":"B130","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur J Sport Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071638","article-title":"Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease","volume":"9","author":"Fougerat","year":"2020","journal-title":"Cells"},{"key":"B133","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","author":"Liss","year":"2017","journal-title":"Biochimie"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2012.04.028","article-title":"Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes","volume":"685","author":"Qiang","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22157841","article-title":"Losartan prevents hepatic steatosis and macrophage polarization by inhibiting HIF-1\u03b1 in a murine model of NAFLD","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328357f747","article-title":"Vitamin E and nonalcoholic fatty liver disease","volume":"15","author":"Pacana","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007929","article-title":"IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis","volume":"4","author":"Mas","year":"2009","journal-title":"PloS One"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27016","article-title":"Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer","volume":"60","author":"Aleksandrova","year":"2014","journal-title":"Hepatology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092406","article-title":"Interleukin-6: A new marker of advanced-sarcopenic HCC cirrhotic patients","volume":"15","author":"Dalbeni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1568","article-title":"STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review)","volume":"41","author":"Wang","year":"2012","journal-title":"Int J Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.08.009","article-title":"Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro","volume":"341","author":"Wilson","year":"2013","journal-title":"Cancer Lett"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12141","article-title":"The vagus nerve attenuates fulminant hepatitis by activating the Src kinase in Kuppfer cells","volume":"79","author":"Li","year":"2014","journal-title":"Scand J Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.12.028","article-title":"Hepatic oncostatin M receptor \u03b2 Regulates obesity-induced steatosis and insulin resistance","volume":"186","author":"Luo","year":"2016","journal-title":"Am J Pathol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.03.228","article-title":"Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis","volume":"165","author":"Han","year":"2023","journal-title":"Gastroenterology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310711121","article-title":"CLCF1 inhibits energy expenditure via suppressing brown fat thermogenesis","volume":"121","author":"Yuan","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B147","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s11658-025-00721-x","article-title":"MAFF alleviates hepatic ischemia-reperfusion injury by regulating the CLCF1\/STAT3 signaling pathway","volume":"30","author":"Lei","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1642436\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:12:29Z","timestamp":1756872749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1642436\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":148,"alternative-id":["10.3389\/fendo.2025.1642436"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1642436","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1642436"}}